Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label crossover pharmacokinetic interaction study of favipiravir with triazolam and metformin in healthy adults
jRCT2031220735Active, not recruiting
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of favipiravir in severe fever with thrombocytopenia syndrome (SFTS) (2 cohorts), sponsored by FUJIFILM Toyama Chemical. Primary endpoints: Plasma concentration–time profile and PK parameters of triazolam, Triazolam PK geometric mean ratios with vs without favipiravir and 3 more. Started Mar 2023; status: active, not recruiting.
02
Drugs
favipiravir
03
Conditions
severe fever with thrombocytopenia syndrome (SFTS)
Beyond the preview
Go deeper on jRCT2031220735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220735.